Glycoengineered Antibody-Drug Conjugates
Corresponding Organization :
Other organizations : Shenyang Pharmaceutical University, Center for Excellence in Molecular Cell Science, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Variable analysis
- Expression of the enzymes Endo-S, PNGase-F, and AlfC in E. coli
- Preparation of glycoengineered azido-herceptin (7) and DBCO-MMAE (8)
- Not explicitly mentioned
- Use of reported procedures for enzyme expression
- Use of previous paper for preparation of glycoengineered compounds
- Purchasing of reagents and solvents from specified suppliers without further purification
- Use of specific analytical equipment (MAbPac RP column, Varian-MERCURY Plus-400 or 500 NMR instrument, Agilent 6230 LC-TOF MS spectrometer)
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!